Protein tyrosine kinases in malignant melanoma - PubMed (original) (raw)
Review
Protein tyrosine kinases in malignant melanoma
D J Easty et al. Melanoma Res. 2000 Oct.
Abstract
Protein tyrosyl phosphorylation is an essential component in intracellular signalling, with diverse and crucial functions including mediation of cell proliferation, survival, death, differentiation, migration and attachment. It is regulated by the balance between the activities of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases. A number of PTKs are encoded by proto-oncogenes or viral oncogenes, and are thus strongly implicated in cancer. While a role for PTKs in human melanoma is less firmly established, human melanomas or melanoma cells have been reported to contain more tyrosine phosphate than normal melanocytes, and some receptor PTKs (EPH-A2/ ECK and EPH-B3) are overexpressed in over 90% of melanoma cell lines. Other specific PTKs are also frequently overexpressed, including KDR and fibroblast growth factor receptor-4 (FGF-R4), while, interestingly, yet others, such as KIT and FES, are consistently downregulated in melanoma cell lines. All of these differentially expressed PTKs are candidates for gene products important in melanoma development. In addition, PTKs expressed in significant amounts in both benign and malignant melanocytes, such as insulin-like growth factor-1 receptor (IGF1-R), FGF-R1, HER2/NEU and FAK, are likely to play a role in melanoma genesis and progression.
Similar articles
- Tyrosine phosphate in melanoma progression.
McArdle L, Bergin O, Fallowfield ME, Dervan PA, Easty DJ. McArdle L, et al. Br J Dermatol. 2003 Aug;149(2):289-95. doi: 10.1046/j.1365-2133.2003.05405.x. Br J Dermatol. 2003. PMID: 12932234 - Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis.
Easty DJ, Herlyn M, Bennett DC. Easty DJ, et al. Int J Cancer. 1995 Jan 3;60(1):129-36. doi: 10.1002/ijc.2910600119. Int J Cancer. 1995. PMID: 7814145 - Novel and known protein tyrosine kinases and their abnormal expression in human melanoma.
Easty DJ, Ganz SE, Farr CJ, Lai C, Herlyn M, Bennett DC. Easty DJ, et al. J Invest Dermatol. 1993 Nov;101(5):679-84. doi: 10.1111/1523-1747.ep12371675. J Invest Dermatol. 1993. PMID: 8228328 - Receptor tyrosine kinases and their activation in melanoma.
Easty DJ, Gray SG, O'Byrne KJ, O'Donnell D, Bennett DC. Easty DJ, et al. Pigment Cell Melanoma Res. 2011 Jun;24(3):446-61. doi: 10.1111/j.1755-148X.2011.00836.x. Epub 2011 Mar 3. Pigment Cell Melanoma Res. 2011. PMID: 21320293 Review. - Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes.
Halaban R, Fan B, Ahn J, Funasaka Y, Gitay-Goren H, Neufeld G. Halaban R, et al. J Immunother (1991). 1992 Oct;12(3):154-61. doi: 10.1097/00002371-199210000-00002. J Immunother (1991). 1992. PMID: 1445804 Review.
Cited by
- Cytotoxic effect of Ad-ephrinA1-caspase-3-T on breast cancer cells in vitro.
Huang Y, Zhang B, Li Y, Li Z, Zhang Q, Zhao B. Huang Y, et al. Transl Cancer Res. 2019 Feb;8(1):104-110. doi: 10.21037/tcr.2019.01.07. Transl Cancer Res. 2019. PMID: 35116739 Free PMC article. - Esophageal carcinoma cell-excreted exosomal uc.189 promotes lymphatic metastasis.
Ding Z, Yan Y, Guo YL, Wang C. Ding Z, et al. Aging (Albany NY). 2021 May 23;13(10):13846-13858. doi: 10.18632/aging.202979. Epub 2021 May 23. Aging (Albany NY). 2021. PMID: 34024769 Free PMC article. - Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation.
Ikonomopoulou MP, Fernandez-Rojo MA, Pineda SS, Cabezas-Sainz P, Winnen B, Morales RAV, Brust A, Sánchez L, Alewood PF, Ramm GA, Miles JJ, King GF. Ikonomopoulou MP, et al. Sci Rep. 2018 Aug 1;8(1):11519. doi: 10.1038/s41598-018-29826-4. Sci Rep. 2018. PMID: 30068931 Free PMC article. - Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines.
Dratkiewicz E, Pietraszek-Gremplewicz K, Simiczyjew A, Mazur AJ, Nowak D. Dratkiewicz E, et al. Oncotarget. 2018 Apr 6;9(26):18254-18268. doi: 10.18632/oncotarget.24810. eCollection 2018 Apr 6. Oncotarget. 2018. PMID: 29719603 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous